A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
Clinical trial NCT07123454 · RECRUITING
Trial details
- NCT number
- NCT07123454
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-24
- Primary completion
- 2028-03-01
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.